No Data
"When will the 'medication' market return? Foreign capital and public offerings are racing to buy these pharmaceutical stocks.
The pharmaceutical industry has always been recognized as a "long slope and thick snow" track, and it is also one of the sectors that capital markets pay the most attention to.
Key stock indices in Hong Kong, major adjustments! 570 billion funds, embracing "change"!
Hang Seng Index latest adjustment! Today, Hang Seng Indexes Company Limited announced that Kuaishou Technology, new oriental education technology group will be included in the Hang Seng Index, while New World Development Company will be removed. The number of constituent stocks in the Hang Seng Index will increase from 82 to 83; China people's property insurance co., ltd. will be included in the Hang Seng H-Share Index ETF, while Longfor group holdings limited will be removed. The number of constituent stocks in the Hang Seng H-Share Index ETF will remain at 50; Midea Group Co., Ltd will be included in the Hang Seng Tech Index, while Weibo Co., Ltd. will be removed. The number of constituent stocks in the Hang Seng Tech Index will remain at 40. Hang Seng Indexes Company Limited stated that all changes will take effect in 2024.
Express News | Six institutions: improve the management of grassroots pharmaceuticals and expand the types of grassroots pharmaceuticals.
The bullish market stimulated the Hong Kong stock pharmaceutical sector, with Laikai Pharmaceutical soaring nearly 20%.
Statistics from the Capital Research Department of Silver (Hong Kong) show that the number of innovative drugs IND and NDA has returned to growth after hitting a low in 2022. In the third quarter of this year, 1033 drug clinical approvals were granted, a 25% year-on-year increase, with a total of 8 first-class innovative drugs approved for marketing, doubling year-on-year.
Will the indications of GLP-1 drugs expand to the field of PCOS? The era of three targets is about to arrive? | Industry Observation
①At the GLP-1 Drug Seminar (Chengdu session), participants discussed the global trend of GLP-1 drug research and development. ②Participants mentioned that the indications for GLP-1 drugs in the future may expand to areas such as PCOS and stroke. ③Drugs targeting GLP, GCG, and GIP receptors are beginning to rise.
The new policy of prepayment of medical insurance fund has been released, and the pharmaceutical sector has ushered in a sharp rise. Experts believe it may be a way for medical institutions to release funding pressure.
On the 11th, the "Notice on Prepayment of Medical Insurance Fund" was issued, requiring the unified and improved basic medical insurance fund prepayment system at the national level. Experts believe that the prepayment system can effectively alleviate the problem of pharmaceutical industry debt, accelerate the turnover of funds for pharmaceutical companies. The medical sector showed a significant upward trend today, with listed companies attributing the rise to investor sentiment.
No Data
No Data